Association Between HLA Alleles and Autoantibodies in Dermatomyositis Defined by Sarcoplasmic Expression of Myxovirus Resistance Protein A

dc.contributor.authorOyama M.
dc.contributor.authorOhnuki Y.
dc.contributor.authorUruha A.
dc.contributor.authorSaito Y.
dc.contributor.authorNishimori Y.
dc.contributor.authorSuzuki S.
dc.contributor.authorInoue M.
dc.contributor.authorTanboon J.
dc.contributor.authorOkiyama N.
dc.contributor.authorShiina T.
dc.contributor.authorNishino I.
dc.contributor.authorSuzuki S.
dc.contributor.otherMahidol University
dc.date.accessioned2023-09-10T18:01:59Z
dc.date.available2023-09-10T18:01:59Z
dc.date.issued2023-09-01
dc.description.abstractOBJECTIVE: The diagnosis in the studies analyzing HLA of dermatomyositis (DM) was based on a combined clinical category of polymyositis/DM. This retrospective study investigated the associations of HLA with 5 DM-specific autoantibodies in Japanese patients diagnosed by muscle pathology. METHODS: We diagnosed Japanese patients with DM based on sarcoplasmic expression of myxovirus resistance protein A. These patients underwent investigation for 5 DM-specific autoantibodies and HLA genotyping. RESULTS: Of 175 patients (83 males and 92 females; range 1-86 yrs; mean 46 yrs), 173 (98.9%) had 1 of the 5 autoantibodies. Seven alleles-A*02:07, B*46:01, DRB1*04:07, DRB1*07:01, DRB1*08:03, DQB1*06:01, and DPB1*02:02-were more frequently detected in the patients with DM than healthy controls, but these associations were not significant after multiple testing correction. Stratifying by DM-specific autoantibodies, we found the associations of 6 already known and 7 new alleles-B*48:01, B*52:01, C*12:02, DRB1*04:05, DRB1*15:02, DPB1*05:01, and DPB1*09:01-with subsets of DM. Moreover, significant associations of 5 alleles with antinucleosome remodeling deacetylase complex (Mi-2) remained after multiple testing correction. In particular, the DRB1*04:07 (odds ratio [OR 28.9]; corrected P = 2.7 × 10-6) and DQB1*06:01 (OR 4.0; corrected P = 1.6 × 10-4) alleles were significantly more prevalent in patients with anti-Mi-2 antibody than in controls. CONCLUSION: This study demonstrates DM-specific autoantibodies defined immunogenetic subsets of DM.
dc.identifier.citationThe Journal of rheumatology Vol.50 No.9 (2023) , 1159-1164
dc.identifier.doi10.3899/jrheum.2022-1321
dc.identifier.issn0315162X
dc.identifier.pmid37321638
dc.identifier.scopus2-s2.0-85169624822
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/89608
dc.rights.holderSCOPUS
dc.subjectMedicine
dc.titleAssociation Between HLA Alleles and Autoantibodies in Dermatomyositis Defined by Sarcoplasmic Expression of Myxovirus Resistance Protein A
dc.typeArticle
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85169624822&origin=inward
oaire.citation.endPage1164
oaire.citation.issue9
oaire.citation.startPage1159
oaire.citation.titleThe Journal of rheumatology
oaire.citation.volume50
oairecerif.author.affiliationTokai University Hospital
oairecerif.author.affiliationGraduate School of Medical and Dental Sciences
oairecerif.author.affiliationTokyo Metropolitan Neurological Hospital
oairecerif.author.affiliationTokai University School of Medicine
oairecerif.author.affiliationKeio University School of Medicine
oairecerif.author.affiliationNational Institute of Neuroscience, Kodaira

Files

Collections